全文获取类型
收费全文 | 2689篇 |
免费 | 300篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 93篇 |
妇产科学 | 93篇 |
基础医学 | 270篇 |
口腔科学 | 187篇 |
临床医学 | 234篇 |
内科学 | 669篇 |
皮肤病学 | 37篇 |
神经病学 | 99篇 |
特种医学 | 64篇 |
外科学 | 329篇 |
综合类 | 72篇 |
预防医学 | 285篇 |
眼科学 | 147篇 |
药学 | 229篇 |
中国医学 | 11篇 |
肿瘤学 | 158篇 |
出版年
2023年 | 39篇 |
2022年 | 120篇 |
2021年 | 158篇 |
2020年 | 103篇 |
2019年 | 145篇 |
2018年 | 175篇 |
2017年 | 106篇 |
2016年 | 119篇 |
2015年 | 101篇 |
2014年 | 140篇 |
2013年 | 177篇 |
2012年 | 220篇 |
2011年 | 213篇 |
2010年 | 127篇 |
2009年 | 84篇 |
2008年 | 130篇 |
2007年 | 111篇 |
2006年 | 101篇 |
2005年 | 123篇 |
2004年 | 77篇 |
2003年 | 55篇 |
2002年 | 55篇 |
2001年 | 16篇 |
2000年 | 33篇 |
1999年 | 30篇 |
1998年 | 24篇 |
1997年 | 19篇 |
1996年 | 16篇 |
1995年 | 12篇 |
1994年 | 7篇 |
1993年 | 12篇 |
1992年 | 13篇 |
1991年 | 19篇 |
1990年 | 14篇 |
1989年 | 14篇 |
1988年 | 16篇 |
1987年 | 14篇 |
1986年 | 12篇 |
1985年 | 4篇 |
1984年 | 9篇 |
1982年 | 2篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1976年 | 3篇 |
1973年 | 2篇 |
1971年 | 2篇 |
1967年 | 2篇 |
1949年 | 1篇 |
排序方式: 共有3000条查询结果,搜索用时 15 毫秒
91.
92.
Chirk Jenn Ng Yew Kong Lee Adina Abdullah Ahmad Ihsan Abu Bakar Abdul Malik Tun Firzara Han Wei Tiew 《Journal of evaluation in clinical practice》2019,25(6):1074-1079
It is common for primary care providers (PCPs) to manage complex multimorbidity. When caring for patients with multimorbidity, PCPs face challenges to tackle several issues within a short consultation in order to address patients' complex needs. Furthermore, some PCPs may lack access to a multidisciplinary team and need to manage multimorbidity within the confine of a PCP‐patient partnership only. Instead of attempting to address multiple health issues within a single consultation, it would be more feasible and time effective for PCPs and patients to jointly prioritize the health issue to focus on. Using the Malaysian primary care setting as a case study, a dual‐layer‐shared decision‐making approach is proposed whereby PCPs and patients make decisions on which disease(s) (layer 1) and treatment(s) (layer 2) to prioritize. This dual‐layer model aims to address the challenges of short consultation time and limited healthcare resources by encouraging PCPs and patients to discuss, negotiate, and agree on the decision during the consultation to ensure patients' health needs are addressed. 相似文献
93.
Bashir A Hassan AA Salmah MR Rahman WA 《The Southeast Asian journal of tropical medicine and public health》2008,39(2):222-228
The efficacy of the larvicidal and pupicidal agent (Agnique) MMF was evaluated against larvae of An. arabiensis and Culex (Diptera: Culicidae) under field conditions in Bahary Locality, Khartoum, Sudan. At an applied dosage of 0.25 ml/m2, MMF resulted in 89.4, 79.8 and 88.2% reductions in L3-L4 instars An. arabiensis and 63.5% in Culex larvae (all stages) 24 to 72 hours post-treatment. Pupae were completely eliminated (100%) within 24 hours posttreatment. The earlier instars (L1-L2) of An. arabiensis were more tolerant with a 62.5% reduction at 72 hours post-treatment compared to (L3-L4) instars and pupae. At 7-days post-treatment Agnique gave a 57.5% reduction in L1-L2 and 92.6% in L3-L4 instar larvae of An. arabiensis and 57.3% and 86.4% in Culex larvae and pupae, respectively. We conclude that Agnique can perform effectively against L3-L4 instars and pupae of An. arabiensis for only 1 week, and 3 to 4 days against L1-L2 instars of Culex spp. 相似文献
94.
Nasruddin Jaafar Hina Hakim Nor Azlida Mohd Nor Asma Mohamed Roslan Saub Rashidah Esa Jennifer Doss Zamros Yuzadi Mohd Yusof Norintan Ab-Murat Noor Lide Abu Kassim Hazreen Abdul Majid 《BMC public health》2014,14(Z3):S2
Background
The urban low income has often been assumed to have the greatest dental treatment needs compared to the general population. However, no studies have been carried out to verify these assumptions. This study was conducted to assess whether there was any difference between the treatment needs of an urban poor population as compared to the general population in order to design an intervention programme for this community.Methods
A random sampling of living quarters (households) in the selected areas was done. 586 adults over 19 years old living in these households were clinically examined using World Health Organization (WHO) Oral Health Survey criteria 4th edition (1997).Results
The overall prevalence of dental caries, periodontal disease, denture wearers and temporomandibular joint problems were 70.5%, 97.1%, 16.7% and 26%, respectively. The majority (80.5%) needed some form of dental treatment. The highest treatment needs were found in the oldest age group while the lowest were in the youngest group (19-29 years) (p = 0.000). The most prevalent periodontal problem was calculus; regardless of gender, ethnicity and age. Significantly more females (20.5%) wore prosthesis than males (11.1%) (p = 0.003). Prosthetic status and need significantly increased with age (p = 0.000). About one in four adults had Temporo-Mandibular Joint (TMJ) problems. Overall, it was surprising to note that the oral disease burden related to caries, prosthetic status and treatment need were lower in this population as compared to the national average (NOHSA, 2010). However, their periodontal disease status and treatment needs were higher compared to the national average indicating a poor oral hygiene standard.Conclusions
The evidence does not show that the overall oral disease burden and treatment needs in this urban disadvantaged adult population as higher than the national average, except for periodontal disease. The older age groups and elderly were identified as the most in need for oral health intervention and promotion. An integrated health intervention programme through a multisectoral common risk factor approach in collaboration with the Faculties of Medicine, Dentistry and other agencies is needed for the identified target group.95.
96.
A. S. Soin R. Mohanka N. Saraf A. Rastogi S. Goja B. Menon V. Vohra S. Saigal R. Sud D. Kumar P. Bhangui S. Ramachandra P. Singla G. Shetty K. Raghvendra Kareem M. Abu Elmagd 《Indian journal of gastroenterology》2014,33(2):104-113
Intestinal transplant is a therapeutic challenge not just surgically but also logistically because of the multidisciplinary expertise and resources required. A large proportion of patients who undergo massive bowel resection and develop intestinal failure have poor outcome, because of inability to sustain long-term parenteral nutrition and limited availability of intestinal and multi-visceral transplantation facilities. We report the first successful isolated intestinal transplant from India. 相似文献
97.
Jaydip M. Vasoya Heta H. Desai Suhas G. Gumaste John Tillotson Donald Kelemen Damon M. Dalrymple Abu T.M. Serajuddin 《Journal of pharmaceutical sciences》2019,108(2):888-896
Various polyoxylglycerides have been researched extensively in the development of solid dispersions (SDs) for bioavailability enhancement of poorly water-soluble drugs. However, because of their low melting points (40°C-60°C), SDs produced are usually soft and semisolid. The objective of present study was to prepare SDs of a Biopharmaceutical Classification System class II drug, carvedilol, in mixtures of stearoyl polyoxylglycerides (Acconon® C-50; m.p. ~50°C) with polymers by hot melt extrusion to obtain free-flowing powder upon grinding. Miscibility of carvedilol with Kollidon® VA64, hydroxypropyl methylcellulose acetate succinate, and Klucel? EXF was first evaluated by film casting, and Kollidon® VA64 was selected for further study. SDs containing 5%-20% carvedilol, 0%-20% Acconon® C-50, and the remaining Kollidon® VA64 were prepared for hot melt extrusion. SDs were characterized by differential scanning calorimetry and powder X-ray diffraction analysis, and dissolution tests were conducted in 250 mL of pH 6.8 phosphate buffer by filling powders in capsules. Carvedilol was miscible with all polymers tested up to 50% and remained amorphous in SDs. The drug release from formulations containing 20% carvedilol and 0, 5%, 10%, and 20% Acconon® C-50 were 30%, 30%, 70%, and 90%, respectively, in 60 min. SDs containing carvedilol and Acconon® C-50, up to 20% each, as well as Kollidon® VA64, were physically stable after 3 months of storage at 25°C/60% relative humidity. 相似文献
98.
Bahaa Abu Raya Isaac Srugo Aharon Kessel Michael Peterman David Bader Ron Gonen Ellen Bamberger 《Vaccine》2014
Background
The Centers for Disease Control and Prevention recommend Tdap immunization during pregnancy, preferably at 27–36 weeks.Aim
To ascertain whether there is a preferential period of maternal Tdap immunization during pregnancy that provides the highest concentration of pertussis-specific antibodies to the newborn.Methods
This prospective study measured pertussis-specific antibodies in paired maternal-cord sera of women immunized with Tdap after the 20th week of their pregnancy (n = 61).Results
The geometric mean concentrations (GMCs) of Immunoglobulin G (IgG) to pertussis toxin (PT) were higher in the newborns’ cord sera when women were immunized at 27–30+6 weeks (n = 21) compared with 31–36 weeks (n = 30) and >36 weeks (n = 7), 46.04 international units/milliliter (IU/mL) (95% CI, 24.29–87.30) vs. 8.69 IU/mL (95% CI, 3.66–20.63) and 21.12 IU/mL (95% CI, 7.93–56.22), p < 0.02, respectively. The umbilical cord GMCs of IgG to filamentous hemagglutinin (FHA) were higher in the newborns’ cord sera when women were immunized at 27–30+6 weeks compared with 31–36 weeks and >36 weeks, 225.86 IU/mL (95% CI, 182.34–279.76) vs. 178.31 IU/mL (95% CI, 134.59–237.03) and 138.03 IU/mL (95% CI, 97.61–195.16), p < 0.02, respectively.Conclusions
Immunization of pregnant women with Tdap between 27–30+6 weeks was associated with the highest umbilical cord GMCs of IgG to PT and FHA compared with immunization beyond 31 weeks gestation. Further research should be conducted to reaffirm these finding in order to promote an optimal pertussis controlling policy. 相似文献99.
Taufiqur R. Bhuiyan Feroza K. Choudhury Farhana Khanam Amit Saha Md. Abu Sayeed Umme Salma Anna Lundgren David A. Sack Ann-Mari Svennerholm Firdausi Qadri 《Vaccine》2014
Young children are very susceptible to typhoid fever, emphasizing the need for vaccination in under five age groups. The parenteral Vi polysaccharide vaccine is not immunogenic in children under 2 years and the oral Ty21a vaccine (Vivotif) available in capsular formulation is only recommended for those over 5 years. 相似文献
100.
Md. Abu Manju Math J. J. M. Candel Martijn P. F. Berger 《Statistics in medicine》2014,33(15):2538-2553
In this paper, the optimal sample sizes at the cluster and person levels for each of two treatment arms are obtained for cluster randomized trials where the cost‐effectiveness of treatments on a continuous scale is studied. The optimal sample sizes maximize the efficiency or power for a given budget or minimize the budget for a given efficiency or power. Optimal sample sizes require information on the intra‐cluster correlations (ICCs) for effects and costs, the correlations between costs and effects at individual and cluster levels, the ratio of the variance of effects translated into costs to the variance of the costs (the variance ratio), sampling and measuring costs, and the budget. When planning, a study information on the model parameters usually is not available. To overcome this local optimality problem, the current paper also presents maximin sample sizes. The maximin sample sizes turn out to be rather robust against misspecifying the correlation between costs and effects at the cluster and individual levels but may lose much efficiency when misspecifying the variance ratio. The robustness of the maximin sample sizes against misspecifying the ICCs depends on the variance ratio. The maximin sample sizes are robust under misspecification of the ICC for costs for realistic values of the variance ratio greater than one but not robust under misspecification of the ICC for effects. Finally, we show how to calculate optimal or maximin sample sizes that yield sufficient power for a test on the cost‐effectiveness of an intervention. Copyright © 2014 John Wiley & Sons, Ltd. 相似文献